Fortis Healthcare Q1 Results FY26: Q1 PAT Rises 56.83% to ₹260.28 Crore; Revenue Up 16.56% YoY

Fortis Healthcare Q1 Results FY26: Fortis Healthcare posted its Q1 results on 6th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹260.28 crores against revenue of ₹2,166.72 crores. During Q1 FY26, the profit increase of the company was recorded at 56.83% YoY, and the revenue increase for the same period was 16.56%. 

Fortis Healthcare Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

Fortis Healthcare Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Fortis Healthcare Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Fortis Healthcare clocked Q1 FY26 consolidated revenue of ₹2,166.72 crores vs ₹1,858.90 crores. 
• On the profit front, Fortis Healthcare earned a consolidated PAT of ₹260.28 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹165.96 crore. 
• Consolidated PAT rose for the first quarter of FY26, was 56.83% YoY, and revenue rose 16.56% YoY. 
• As per the standalone figures, the quarterly PAT of Fortis Healthcare has increased by 93.37%, and revenue has increased by 29.88% YoY.

Fortis Healthcare Share Price Performance

On the opening bell of 7th August 2025, the shares of Fortis Healthcare opened at ₹881.95 per share. However, the initial gains are sustained as of now, and Fortis Healthcare shares are trading at ₹887.90 per share, higher than their opening price. 

Considering the long-term performance, Fortis Healthcare shares have yielded close to 82.70% returns in the past 1 year, and 5-year returns stand at 543.48%. Over the maximum timeframe, the Fortis Healthcare share provided 783.58% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Fortis Healthcare shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : Maruti Suzuki Q1 Results FY26: Q1 PAT Soars 0.87% to ₹3,792.40 Crore; Revenue Surged 7.90% YoY

Recent Articles

Krishna Institute of Medical Sciences Q1 Results FY26: Q1 PAT Narrows 9.24% to ₹78.60 Crore; Revenue Jumps 26.61% YoY

RITES Q1 Results FY26: Q1 PAT Jumps 1.37% to ₹80.10 Crore; Revenue Surges 0.82% YoY

Godrej Agrovet Q1 Results FY26: Q1 Rises 18.77% to ₹160.52 Crore; Revenue Soars 11.21% YoY

Connplex Cinemas IPO GMP: Day 1 IPO Live Updates

JSW Cement IPO GMP: Day 1 IPO Live Updates